Activity Provided By:

ACHL

Ready for a Closeup: Differentiating Inadequate Response and Emotional Blunting During Treatment for Major Depressive Disorder

Overview / Abstract:	Major depressive disorder (MDD) can have a significant impact on your patients’ lives. However, MDD is not just about feeling “down.” It’s a life-threatening condition that is a leading cause of suicide. Fortunately, there are a variety of effective therapies; however, many patients may experience an inadequate response to treatment and others may have experience anhedonia or reduced emotional responsiveness (ie, emotional blunting) associated with both selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors (SSRIs/SNRIs). Do you have questions about the symptoms of emotional blunting or differentiating emotional blunting from inadequate treatment response? What about assessing the effectiveness of different therapies? Access this innovative “cinemeducation” format in which representative patient and clinician dialogues come to life to model best practices. Find out how to use measurement-based care for tracking symptoms of depression; assess and manage treatment-related emotional blunting; and involve patients in shared decision making. Enhance your clinical practices and help your patients find the light again.
Expiration	Sep 29, 2024
Discipline(s)	Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE, Social Work CE
Format	Online, Webinar / Webcast / Video
Credits / Hours	0.75
Accreditation	ACCME
Presenters / Authors / Faculty	Roger McIntyre, MD, FRCPC (Chair) Professor of Psychiatry and Pharmacology University of Toronto Chairman and Executive Director Brain and Cognition Discovery Foundation Toronto, ON Anita Clayton, MD (Faculty) David C. Wilson Professor and Chair Department of Psychiatry and Neurobehavioral Sciences Professor of Clinical Obstetrics and Gynecology University of Virginia School of Medicine Charlottesville, VA
Sponsors / Supporters / Grant Providers	Provided by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Keywords / Search Terms	ACHL cinemeducation, real-world practice, case-based experience, expert discussion, patient risk factors, emotional blunting, major depressive disorder, expert perspectives, therapy, treatment strategies, measurement-based care, MBC, shared decision making, treatment, depression, depression research, antidepressant, dose-response effect, depression therapy comparison, emotional blunting monitoring, dosing, patient education Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map